EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

The role of platelets and megakaryocytes in sepsis and ARDS

Gabriel Leung, Elizabeth A Middleton iD

The Journal of Physiology · 2024-11 · 602 (22) · 6047-6063

DOI: 10.1113/jp284879 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2024-10-19. Written by Gabriel Leung and 1 co-authors. Institution: Division of Pulmonary, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. Major MEDLINE topics: Megakaryocytes, Sepsis, Respiratory Distress Syndrome, Blood Platelets. Cited 21 times so far (Crossref); 126 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NHLBI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Since the global COVID‐19 pandemic, there has been a renewed focus on lung injury during infection. Systemic inflammatory responses such as acute respiratory distress syndrome (ARDS) and sepsis are a leading cause of morbidity and mortality for both adults and children. Improvements in clinical care have improved outcomes but mortality remains ∼40% and significant morbidity persists for those patients with severe disease. Mechanistic studies of the underlying biological processes remain essential to identifying therapeutic targets. Furthermore, methods for identifying the underlying drivers of organ failure are key to treating and preventing tissue injury. In this review, we discuss the contribution of megakaryocytes (MKs) and platelets to the pathogenesis of systemic inflammatory syndromes. We explore the role of MKs and the new identification of extramedullary MKs during sepsis. We describe the alterations in the platelet transcriptome during sepsis. Lastly, we explore platelet function as defined by aggregation, activation and the formation of heterotypic aggregates. Much more work is necessary to explore the contribution of platelets to these heterogenous syndromes, but the foundation of platelets as key contributors to inflammation has been laid. image

Subjects

MeSH terms (MEDLINE)

MegakaryocytesSepsisRespiratory Distress SyndromeBlood PlateletsHumansAnimalsCOVID-19

Author keywords

ARDSimmunothrombosismegakaryocyteplateletsepsis

Authors and institutions

  • Division of Pulmonary, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.

ORCID profiles: Elizabeth A Middleton

Funding

  • NHLBI NIH HHS

Cite

APA

Leung, G., & Middleton, E. A. (2024). The role of platelets and megakaryocytes in sepsis and ARDS. The Journal of Physiology, 602(22), 6047-6063. https://doi.org/10.1113/jp284879

Vancouver

Leung G, Middleton EA. The role of platelets and megakaryocytes in sepsis and ARDS. The Journal of Physiology. 2024;602(22):6047-6063. doi:10.1113/jp284879

BibTeX
@article{Leung2024,
  author = {Leung, Gabriel and Middleton, Elizabeth A},
  title = {The role of platelets and megakaryocytes in sepsis and ARDS},
  journal = {The Journal of Physiology},
  year = {2024},
  volume = {602},
  number = {22},
  pages = {6047--6063},
  doi = {10.1113/jp284879}
}
Start for free →